Europe medicines watchdog to update on AstraZeneca vaccine safety 7 or 8 April

Coronavirus chronicle

Reuters
06 April, 2021, 07:25 pm
Last modified: 06 April, 2021, 07:27 pm
A spokeswoman for the European Medicines Agency said its pharmaceuticals risk assessment committee has not reached a conclusion in its current review of the vaccine's safety
Vials labelled "Astra Zeneca COVID-19 Coronavirus Vaccine" and a syringe are seen in front of a displayed AstraZeneca logo, in this illustration photo taken March 14, 2021. REUTERS/Dado Ruvic/Illustration/File Photo/File Photo

The European medicines watchdog expects to hold a press conference this week updating the public on its review of rare blood clotting cases in people who have received the AstraZeneca Covid-19 vaccine, a spokeswoman said on Tuesday.

In an emailed response to questions, a spokeswoman for the European Medicines Agency said its pharmaceuticals risk assessment committee has not reached a conclusion in its current review of the vaccine's safety, and it expects to hold a press briefing "as soon as the review is finalized," either on April 7 or April 8.

Related Topics

AstraZeneca Covid-19 Vaccine / European Medicines Agency (EMA)

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.